Sept. 16, 2004 — The U.S. Food and Drug Administration (FDA) has approved a new implantable intraocular lens for moderate to severe nearsightedness, the use of Guidant's cardiac resynchronization ...
Indianapolis, IN and St Paul, MN - The FDA has approved Guidant Corporation's Contak CD®/Easytrak® system for the treatment of severe heart failure (HF), making it the first biventricular pacer - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results